BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust (BMEZ) is an emerging innovator in the healthcare sector, dedicated to improving patient outcomes through innovative treatments, medical devices, and healthcare solutions. The company operates across global and international markets, addressing critical medical needs and advancing healthcare innovation. As a closed-end fund managed by BlackRock, it invests primarily in health sciences companies, aiming to provide long-term capital appreciation and income. The trust focuses on identifying opportunities in biotechnology, pharmaceuticals, medical technology, and healthcare services, leveraging BlackRock's extensive research capabilities to select investments that have the potential to drive transformative change in healthcare.

BlackRock Health Sciences Term Trust (BMEZ) is listed on the New York Stock Exchange (NYSE) under the ticker symbol BMEZ. The trust trades in US Dollars (USD), as it is based in the United States and its assets are primarily denominated in USD. Being listed on the NYSE provides investors with liquidity and access to one of the world's largest stock exchanges. The trust's net asset value (NAV) and market price are quoted in USD, making it accessible to both domestic and international investors who can trade in US dollars.

BlackRock Health Sciences Term Trust (BMEZ) operates in the Financial Services sector, specifically within the Asset Management industry. As an asset management company, BMEZ is a closed-end fund that pools investor capital to invest in a diversified portfolio of health sciences companies. While its underlying investments are in healthcare, the trust itself is classified under Financial Services because its primary business is managing investments rather than directly providing healthcare services. This classification is common for investment trusts and funds that focus on specific sectors.

BlackRock Health Sciences Term Trust (BMEZ) is based in the United States and operates across global and international markets. The trust invests in health sciences companies worldwide, with a focus on addressing critical medical needs and advancing healthcare innovation. While its headquarters and primary listing are in the US, its investment portfolio includes companies from various regions, allowing it to capture opportunities in different healthcare markets. The trust's global reach enables it to benefit from advancements in medical technology and treatments across developed and emerging economies, providing diversification and exposure to a broad range of healthcare innovations.